Historically, medication assisted treatment (MAT) waiver training has been available for physicians, nurse practitioners, and physician assistants interested in seeking to apply for their waiver to prescribe buprenorphine in the treatment of opioid use disorders. To obtain the waiver to prescribe buprenorphine, providers were required to take eight hours of training.
On April 27, 2021, HHS released New Buprenorphine Practice Guidelines, Expanding Access to Treatment for Opioid Use Disorder no longer requiring the completion of 8 hours waiver training course. However, in recognition that many practitioners will still want and need training on the clinical induction and management of Buprenorphine, PCSS-MAT, the Central East ATTC and DSAMH have partnered to bring this training.
This training will provide information about these new practice guidelines as well as the clinical aspects of Buprenorphine prescribing. PCSS-MAT has a comprehensive library of materials (many are designated for AMA PRA Category 1 CreditTM) available at no cost created to give healthcare providers confidence in treating their patients more effectively. PCSS-MAT also has a no-cost clinical coaching/mentoring program to provide one-on-one clinical expertise for primary care providers.
Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.